Did you know the world’s first FeNO testing machine was developed by the team behind NIOX®? It was 1.5m tall and 70cm wide! Our cutting-edge technology has come a long way since then. So this time, here’s a little about the story of the FeNO evolution.  ..read more

Fractional exhaled nitric oxide, known as FeNO, testing and spirometry can make a valuable pairing in asthma care. In this episode, we’re looking at how these two pieces of the respiratory puzzle can help to complete the picture ..read more

We spoke to FeNO expert Professor Kjell Alving about the science behind foods that affect a patient’s level of fractional exhaled nitric oxide, or FeNO. There’s more to it than meets the eye so let’s get started ..read more

As athletes strive to achieve their goals, one area of increasing focus is the role of respiratory health in sports performance. Studies show that FeNO testing is one of the tools that can help. FeNO isn’t just for elite performers either. The role of FeNO in the management of daily exercise-induced problems among school children has also been examined. Today, we’re talking about some of the highlights ..read more

Research has shown that cigarette smoking can reduce fractional exhaled nitric oxide – or FeNO – by around 60%1but what about vaping? Electronic or ‘e-cigarettes’ have gained significant popularity in recent years as an alternative to traditional tobacco smoking. However, concerns have been raised regarding the potential impact on public health. One aspect of particular interest to the respiratory community is whether vaping affects FeNO levels. In this episode, we explore the evidence ..read more

This month marks 25 years of FeNO testing by NIOX®, a company founded by the same scientists who originally discovered its benefits in asthma care ..read more

To mark World Asthma Day, in this episode our lead nurse for education and support, Karen Frankland, talks to broadcaster Will Luscombe to discuss how asthma treatment can be enhanced with the help of FeNO testing ..read more

A FeNO level greater than 40 parts per billion – or ppb – means asthma is seven times more likely, making FeNO a useful biomarker in suspected cases. But why is FeNO higher in asthma patients? This episode looks at the science ..read more

Over-reliance on short-acting β2-agonists, known as SABA, may indicate poor asthma control. Some people are collecting more than 50 canisters a year when the recommendation is one or two! In this episode, we look at the facts and ..read more

In this episode, we’re looking at what is important when measuring FeNO levels and how the technology behind NIOX VERO® addresses these needs ..read more